Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1175175 (
SARS
)
19,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Understanding when
SARS
-CoV-2 emerged is critical to evaluating our current approach to monitoring novel zoonotic pathogens and understanding the failure of early containment and mitigation efforts for COVID-19. We employed a coalescent framework to combine retrospective molecular clock inference with forward epidemiological simulations to determine how long
SARS
-CoV-2 could have circulated prior to the time of the most recent common ancestor. Our results define the period between mid-October and mid-November 2019 as the plausible interval when the first case of
SARS
-CoV-2 emerged in Hubei province. By characterizing the likely dynamics of the virus before it was discovered, we show that over two-thirds of
SARS
-CoV-2-like zoonotic events would be self-limited, dying out without igniting a pandemic. Our findings highlight the shortcomings of
zoonosis
surveillance approaches for detecting highly contagious pathogens with moderate mortality rates.
...
PMID:Timing the SARS-CoV-2 Index Case in Hubei Province. 3326 53
Over the past decade, pandemics caused by pandemic H1N1 (pH1N1) influenza virus in 2009 and
severe acute respiratory syndrome
virus type 2 (
SARS
-CoV-2) in 2019 have emerged. Both are high-impact respiratory pathogens originating from animals. Their wide distribution in the human population subsequently results in an increased risk of human-to-animal transmission: reverse
zoonosis
. Although there have only been rare reports of reverse
zoonosis
events associated with the ongoing coronavirus disease 2019 (COVID-19) pandemic from
SARS
-CoV-2 so far, comparison with the pH1N1 influenza pandemic can provide a better understanding of the possible consequences of such events for public and animal health. The results of our review suggest that similar factors contribute to successful crossing of the host species barriers in both pandemics. Specific risk factors include sufficient interaction between infected humans and recipient animals, suitability of the animal host factors for productive virus infection, and suitability of the animal host population for viral persistence. Of particular concern is virus spread to susceptible animal species, in which group housing and contact network structure could potentially result in an alternative virus reservoir, from which reintroduction into humans can take place. Virus exposure in high-density populations could allow sustained transmission in susceptible animal species. Identification of the risk factors and serological surveillance in
SARS
-CoV-2-susceptible animal species that are group-housed should help reduce the threat from reverse
zoonosis
of COVID-19.
...
PMID:Reverse Zoonosis of COVID-19: Lessons From the 2009 Influenza Pandemic. 3329 43
<< Previous
1
2
3
4
5
6